Middle East is next market for PromarkerD immunoassay test
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- PromarkerD clinical assay performance results published
- Proteomics receives $1.1 million in R&D tax incentive
- Completion of Placement and Appendix 2A
- September 2020 Quarterly Activities Report and Appendix 4C
- Proteomics International raises $6m in successful Placement
Later from Proteomics International Laboratories
- AGM Investor Presentation
- December 2020 Quarterly Activities Report and Appendix 4C
- Proteomics International seeks FDA approval for PromarkerD
- Response to Price Query
- ISO 13485 certification received - Manufacturing Update
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories